Epigenetics,
Год журнала:
2022,
Номер
17(12), С. 1646 - 1660
Опубликована: Март 21, 2022
Immune
cell-type
composition
changes
with
age,
potentially
weakening
the
response
to
infectious
diseases.
Profiling
epigenetics
marks
of
immune
cells
can
help
us
understand
relationship
disease
severity.
We
therefore
leveraged
a
targeted
DNA
methylation
method
study
differences
in
cohort
pneumonia
patients
(both
COVID-19
positive
and
negative)
unaffected
individuals
from
peripheral
blood.
Clinical Epigenetics,
Год журнала:
2021,
Номер
13(1)
Опубликована: Май 25, 2021
There
are
no
prior
reports
that
compare
differentially
methylated
regions
of
DNA
in
blood
samples
from
COVID-19
patients
to
collected
before
the
SARS-CoV-2
pandemic
using
a
shared
epigenotyping
platform.
We
performed
genome-wide
analysis
circulating
CpG
methylation
Infinium
Human
MethylationEPIC
BeadChip
on
124
hospitalized
COVID-19-positive
and
COVID-19-negative
compared
these
data
with
previously
reported
39
healthy
individuals
pandemic.
Prospective
outcome
measures
such
as
COVID-19-GRAM
risk-score
mortality
were
combined
data.Global
mean
levels
did
not
differ
between
pre-pandemic
controls.
About
75%
acute
illness-associated
located
near
gene
promoter
hypo-methylated
comparison
Gene
ontology
analyses
revealed
terms
associated
immune
response
viral
infections
leukocyte
activation;
disease
predominance
autoimmune
disorders.
Among
patients,
worse
outcomes
prevailing
hyper-methylated
status.
Recursive
feature
elimination
identified
77
positions
predictive
severity
measured
by
GRAM-risk
score.Our
contribute
awareness
may
influence
expression
genes
regulate
progression
represent
targetable
process
setting.
Frontiers in Medicine,
Год журнала:
2023,
Номер
10
Опубликована: Март 31, 2023
The
Long
COVID/Post
Acute
Sequelae
of
COVID-19
(PASC)
group
includes
patients
with
initial
mild-to-moderate
symptoms
during
the
acute
phase
illness,
in
whom
recovery
is
prolonged,
or
new
are
developed
over
months.
Here,
we
propose
a
description
pathophysiology
COVID
presentation
based
on
inflammatory
cytokine
cascades
and
p38
MAP
kinase
signaling
pathways
that
regulate
production.
In
this
model,
SARS-CoV-2
viral
infection
hypothesized
to
trigger
dysregulated
peripheral
immune
system
activation
subsequent
release.
Chronic
low-grade
inflammation
leads
brain
microglia
an
exaggerated
release
central
cytokines,
producing
neuroinflammation.
Immunothrombosis
linked
chronic
microclot
formation
decreased
tissue
perfusion
ischemia.
Intermittent
fatigue,
Post
Exertional
Malaise
(PEM),
CNS
"brain
fog,"
arthralgias,
paresthesias,
dysautonomia,
GI
ophthalmic
problems
can
consequently
arise
as
result
elevated
cytokines.
There
abundant
similarities
between
myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS).
DNA
polymorphisms
viral-induced
epigenetic
changes
gene
expression
may
lead
patients,
predisposing
some
develop
autoimmunity,
which
be
gateway
ME/CFS.
Signal Transduction and Targeted Therapy,
Год журнала:
2021,
Номер
6(1)
Опубликована: Авг. 26, 2021
Abstract
Owing
to
the
limitations
of
present
efforts
on
drug
discovery
against
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
and
lack
understanding
biological
regulation
mechanisms
underlying
COVID-19,
alternative
or
novel
therapeutic
targets
for
COVID-19
treatment
are
still
urgently
required.
SARS-CoV-2
infection
immunity
dysfunction
two
main
courses
driving
pathogenesis
COVID-19.
Both
virus
host
factors
potential
antiviral
therapy.
Hence,
in
this
study,
current
strategies
have
been
classified
into
“target
virus”
host”
categories.
Repurposing
drugs,
emerging
approaches,
promising
implementations
above
strategies.
First,
a
comprehensive
review
highly
acclaimed
old
drugs
was
performed
according
evidence-based
medicine
provide
recommendations
clinicians.
Additionally,
their
unavailability
fight
analyzed.
Next,
profound
analysis
approaches
conducted,
particularly
all
licensed
vaccines
monoclonal
antibodies
(mAbs)
enrolled
clinical
trials
primary
mutant
strains.
Furthermore,
pros
cons
were
compared
from
different
perspectives.
Finally,
most
reviewed,
update
progress
treatments
has
summarized
based
these
reviews.
Clinical Epigenetics,
Год журнала:
2020,
Номер
12(1)
Опубликована: Окт. 21, 2020
Abstract
Epigenetics
is
a
relatively
new
field
of
science
that
studies
the
genetic
and
non-genetic
aspects
related
to
heritable
phenotypic
changes,
frequently
caused
by
environmental
metabolic
factors.
In
host,
epigenetic
machinery
can
regulate
gene
expression
through
series
reversible
modifications,
such
as
histone
methylation
acetylation,
DNA/RNA
methylation,
chromatin
remodeling,
non-coding
RNAs.
The
coronavirus
disease
19
(COVID-19)
highly
transmittable
pathogenic
viral
infection.
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2),
which
emerged
in
Wuhan,
China,
spread
worldwide,
causes
it.
COVID-19
severity
consequences
largely
depend
on
patient
age
health
status.
this
review,
we
will
summarize
comparatively
analyze
how
viruses
host
epigenome.
Mainly,
be
focusing
respiratory
RNA
virus
infections
coronaviruses.
context,
alterations
might
play
an
essential
role
onset
complications.
Although
many
therapeutic
approaches
are
under
study,
more
research
urgently
needed
identify
effective
vaccine
or
safer
chemotherapeutic
drugs,
including
cope
with
outbreak
develop
pre-
post-exposure
prophylaxis
against
COVID-19.
Nature Reviews Cardiology,
Год журнала:
2021,
Номер
19(5), С. 314 - 331
Опубликована: Дек. 6, 2021
The
lungs
are
the
primary
target
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection,
with
hypoxia
being
cause
death
in
most
critical
cases.
Coronavirus
disease
2019
(COVID-19)
is
extremely
heterogeneous
terms
severity,
clinical
phenotype
and,
importantly,
global
distribution.
Although
majority
affected
patients
recover
from
many
continue
to
suffer
late
sequelae
affecting
various
organs,
including
lungs.
role
pulmonary
vascular
system
during
and
chronic
stages
COVID-19
has
not
been
adequately
studied.
A
thorough
understanding
origins
dynamic
behaviour
SARS-CoV-2
virus
potential
causes
heterogeneity
essential
for
anticipating
treating
disease,
both
stages,
development
hypertension.
Both
hypertension
have
assumed
dimensions,
complex
interactions.
In
this
Review,
we
present
an
update
on
discuss
COVID-19.
addition,
summarize
pathobiology
COVID-19,
emphasis
vasculature,
stage
developing
We
hope
that
information
presented
Review
will
help
strategies
prevention
treatment
continuing
pandemic.
Cell Biology International,
Год журнала:
2021,
Номер
45(6), С. 1158 - 1174
Опубликована: Фев. 16, 2021
Since
December
2019,
a
new
form
of
severe
acute
respiratory
syndrome
(SARS)
from
novel
strain
coronavirus
(SARS
2
[SARS-CoV-2])
has
been
spreading
worldwide.
The
disease
caused
by
SARS-CoV-2
was
named
Covid-19
and
declared
as
pandemic
the
World
Health
Organization
in
March
2020.
Clinical
symptoms
range
common
cold
to
more
defined
pneumonia,
hypoxia,
distress.
In
next
stage,
can
become
critical
with
failure,
sepsis,
septic
shock,
and/or
multiorgan
failure.
Outcomes
indicate
large
gaps
between
male-female
young-elder
groups.
Several
theories
have
proposed
explain
variations,
such
gender,
age,
comorbidity,
genetic
factors.
It
is
likely
that
mixture
nongenetic
factors
interplays
virus
host
genetics
determines
severity
outcome.
this
review,
we
aimed
summarize
current
literature
terms
potential
epigenetic
associated
increased
Covid-19.
studies
indicated
variants
entry
mechanism-related
(angiotensin-converting
enzymes,
transmembrane
serine
protease-2,
furin)
innate
immune
response-related
genes
(interferons
[IFNs],
interleukins,
toll-like
receptors),
human
leukocyte
antigen,
ABO,
3p21.31,
9q34.2
loci
are
determinants
related
severity.
Epigenetic
mechanisms
also
affect
outcomes
regulating
IFN
signaling,
angiotensin-converting
enzyme-2,
immunity-related
particularly
escape
X
chromosome
inactivation.
Enhanced
understanding
viral
interactions
for
improved
prognostic
tools
innovative
therapeutics.
Drug Design Development and Therapy,
Год журнала:
2021,
Номер
Volume 15, С. 1819 - 1833
Опубликована: Май 1, 2021
Abstract:
COVID-19
has
caused
a
major
global
health
crisis,
as
excessive
inflammation,
oxidation,
and
exaggerated
immune
response
in
some
sufferers
can
lead
to
condition
known
cytokine
storm,
which
may
progress
acute
respiratory
distress
syndrome
(ARDs),
be
fatal.
So
far,
few
effective
drugs
have
emerged
assist
the
treatment
of
patients
with
COVID-19,
though
herbal
medicine
candidates
fight
against
deaths.
Thymoquinone
(TQ),
main
active
ingredient
black
seed
oil,
possesses
antioxidant,
anti-inflammatory,
antiviral,
antimicrobial,
immunomodulatory
anticoagulant
activities.
TQ
also
increases
activity
number
suppressors,
lymphocytes,
natural
killer
cells,
macrophages,
it
demonstrated
antiviral
potential
viruses,
including
murine
cytomegalovirus,
Epstein-Barr
virus,
hepatitis
C
human
immunodeficiency
other
coronaviruses.
Recently,
notable
SARSCoV-2
strain
isolated
from
Egyptian
and,
interestingly,
molecular
docking
studies
shown
that
could
potentially
inhibit
development
through
binding
receptor-binding
domain
on
spike
envelope
proteins
SARS-CoV-2,
hinder
virus
entry
into
host
cell
its
ion
channel
pore
forming
activity.
Other
an
inhibitory
effect
SARS
CoV2
proteases,
diminish
viral
replication,
good
antagonism
angiotensin-converting
enzyme
2
receptors,
allowing
interfere
uptake
cell.
Several
noted
protective
capability
numerous
chronic
diseases
conditions,
diabetes,
hypertension,
dyslipidemia,
asthma,
renal
dysfunction
malignancy.
recently
been
tested
clinical
trials
for
several
different
diseases,
this
review
thus
aims
highlight
therapeutic
effects
context
pandemic.
Keywords:
thymoquinone,
natural,
benefits
Scientific Reports,
Год журнала:
2022,
Номер
12(1)
Опубликована: Июнь 8, 2022
Although
vaccines
have
been
evaluated
and
approved
for
SARS-CoV-2
infection
prevention,
there
remains
a
lack
of
effective
treatments
to
reduce
the
mortality
COVID-19
patients
already
infected
with
SARS-CoV-2.
The
global
data
on
showed
that
men
higher
rate
than
women.
We
further
observed
proportion
females
increases
starting
from
around
age
55
significantly.
Thus,
sex
is
an
essential
factor
associated
mortality,
related
genetic
factors
could
be
interesting
mechanisms
targets
treatment.
However,
signaling
pathways
remain
unclear.
Here,
we
propose
uncover
potential
using
systematic
integrative
network
analysis.
unique
results
indicated
estrogens,
e.g.,
estrone
estriol,
(1)
interacting
ESR1/2
receptors,
(2)
can
inhibit
caused
inflammation
immune
response
in
host
cells;
(3)
estrogens
are
distinct
fatality
rates
between
male
female
patients.
Specifically,
high
level
estradiol
protects
young
patients,
drop
extremely
low
after
about
years
causing
increased
In
conclusion,
estrogen,
death
by
inhibiting
infection.
Moreover,
medications
boosting
down-stream
ESR1/ESR2,
or
immune-associated
potentially
synergistic
combined
other
existing
drugs
Genes,
Год журнала:
2021,
Номер
12(2), С. 154 - 154
Опубликована: Янв. 25, 2021
The
current
novel
coronavirus
disease
(COVID-19)
has
spread
globally
within
a
matter
of
months.
virus
establishes
success
in
balancing
its
deadliness
and
contagiousness,
causes
substantial
differences
susceptibility
progression
people
different
ages,
genders
pre-existing
comorbidities.
These
host
factors
are
subjected
to
epigenetic
regulation;
therefore,
relevant
analyses
on
some
key
genes
underlying
COVID-19
pathogenesis
were
performed
longitudinally
decipher
their
correlation
susceptibility.
angiotensin-converting
enzyme
2
(ACE2,
as
the
major
receptor)
interleukin
(IL)-6
(a
immuno-pathological
factor
triggering
cytokine
storm)
shown
evince
active
evolution
via
histone
modification
cis/trans-factors
interaction
across
vertebrate
species.
Extensive
revealed
that
ACE2
ad
IL-6
among
subset
non-canonical
interferon-stimulated
(non-ISGs),
which
have
been
designated
for
unconventional
responses
interferons
(IFNs)
inflammatory
stimuli
through
an
cascade.
Furthermore,
significantly
higher
positive
markers
position
weight
matrix
(PWM)
scores
cis-elements
corresponding
IFN
signaling,
discovered
both
IL6
gene
promoters
representative
COVID-19-susceptible
species
compared
unsusceptible
ones.
findings
characterize
non-ISGs
respond
differently
signaling
from
canonical
ISGs.
properties
may
serve
biomarkers
predict
vertebrates
partially
explain
inequality
subgroups.
Emerging Microbes & Infections,
Год журнала:
2022,
Номер
11(1), С. 1371 - 1389
Опубликована: Апрель 27, 2022
Currently,
SARS-CoV-2,
especially
the
Omicron
strain,
is
ravaging
world
and
even
co-infecting
human
beings
with
IAV,
which
a
serious
threat
to
public
health.
As
of
yet,
no
specific
antiviral
drug
has
been
discovered
for
SARS-CoV-2.
This
requires
deeper
understandings
molecular
mechanisms
SARS-CoV-2-host
interaction,
explore
targets
provide
theoretical
basis
developing
anti-SARS-CoV-2
drugs.
article
discussed
comprehensively
studied
expected
most
important
reference
value
SARS-CoV-2
study
apart
from
members
Coronaviridae
family.
We
wish
establish
system
studies
on
virus-host
interaction.
Previous
have
shown
that
host
PRRs
recognize
RNAs
IAV
or
then
activate
innate
immune
signaling
pathways
induce
expression
restriction
factors,
such
as
ISGs,
ultimately
inhibit
viral
replication.
Meanwhile,
viruses
also
evolved
various
regulatory
antagonize
immunity
at
transcriptional,
translational,
post-translational
modification,
epigenetic
levels.
Besides,
can
hijack
supportive
factors
their
Notably,
race
between
antagonism
forms
interaction
networks.
Additionally,
replication
cycle
co-regulated
by
proteins,
ncRNAs,
sugars,
lipids,
hormones,
inorganic
salts.
Given
this,
we
updated
mappings
based
networks
proposed
an
innovative
idea
new
perspectives
immunology
systems
biology.